Ozbay, M. F. Et Al. 2024. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers , vol.16, no.22 .

Ozbay, M. F., Harputluoglu, H., KARACA, M., TEKİN, Ö. F., Şendur, M. A. N., Kaplan, M. A., ... ŞAHİN, B.(2024). Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes. Cancers , vol.16, no.22.

Ozbay, MEHMET Et Al. "Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes," Cancers , vol.16, no.22, 2024

Ozbay, MEHMET F. Et Al. "Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes." Cancers , vol.16, no.22, 2024

Ozbay, M. F. Et Al. (2024) . "Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes." Cancers , vol.16, no.22.

@article{article, author={MEHMET FATİH ÖZBAY Et Al. }, title={Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes}, journal={Cancers}, year=2024}